The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
VistaGen Therapeutics, Inc(NASDAQ:VTGN) 
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset n...
VistaGen Therapeutics Days Payable Outstanding ttm (DPO)
VistaGen Therapeutics Days Receivable Outstanding ttm (DSO)
VistaGen Therapeutics Days Inventory Outstanding ttm (DIO)
VistaGen Therapeutics Op Cashflow Per Share ttm
VistaGen Therapeutics Free Cashflow Per Share ttm
VistaGen Therapeutics Cash Per Share ttm
VistaGen Therapeutics P/S ratio ttm
VistaGen Therapeutics (GAAP) P/E ratio ttm
VistaGen Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.